Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report
Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report
Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report
Submitted by
admin
on November 24, 2017 - 11:36am
Source:
Endpoints
News Tags:
Teva Pharmaceutical
R&D
layoffs
Kåre Schultz
Headline:
Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report
Do Not Allow Advertisers to Use My Personal information
